Monroe Capital acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the strategic investment and continued growth of Spectrum Science (“Spectrum”) by private equity sponsor Knox Lane.
 
Based in Washington D.C., Spectrum is an independent, integrated marketing, communications and media firm focused on the pharmaceutical, biotech and broader life science industries. Spectrum has been serving clients across the healthcare sector for nearly three decades. The partnership with Knox Lane will support the continued expansion of Spectrum’s strategic communications capabilities and allow the company to build on its unique approach to clinical trial recruitment, broaden consultative capabilities for medical affairs clients and drive enhanced tech enablement throughout the organization.